These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 29871263)

  • 1. [Clinical observation of mometasone furoate nasal spray combined with montelukast sodium in the treatment of adenoid hypertrophy in children].
    Liu W; Chen RJ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):366-368. PubMed ID: 29871263
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data.
    Tuhanıoğlu B; Erkan SO
    Turk J Med Sci; 2017 Dec; 47(6):1736-1743. PubMed ID: 29306232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast combined with intranasal mometasone furoate versus intranasal mometasone furoate; a comparative study in treatment of adenoid hypertrophy.
    Ras AE; Hamed MH; Abdelalim AA
    Am J Otolaryngol; 2020; 41(6):102723. PubMed ID: 32950830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children.
    Chohan A; Lal A; Chohan K; Chakravarti A; Gomber S
    Int J Pediatr Otorhinolaryngol; 2015 Oct; 79(10):1599-608. PubMed ID: 26235732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis].
    Jia MH; Chen XY; Zhang Y; Liao ZS
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):369-373. PubMed ID: 29871264
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of montelukast for adenoid hypertrophy in paediatrics: A systematic review and meta-analysis.
    Alanazi F; Alruwaili M; Alanazy S; Alenezi M
    Clin Otolaryngol; 2024 Jul; 49(4):417-428. PubMed ID: 38700144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective reduction in adenoid tissue after mometasone furoate treatment.
    Rezende RM; Silveira F; Barbosa AP; Menezes UP; Ferriani VP; Rezende PH; Anselmo-Lima WT; Valera FC
    Int J Pediatr Otorhinolaryngol; 2012 Jun; 76(6):829-31. PubMed ID: 22425063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mometasone furoate aqueous nasal spray for management of adenoidal hypertrophy in children.
    Bhargava R; Chakravarti A
    J Laryngol Otol; 2014 Dec; 128(12):1060-6. PubMed ID: 25404102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of nasal corticosteroid in preventing regrowth after adenoidectomy.
    Yildirim YS; Senturk E; Eren SB; Dogan R; Tugrul S; Ozturan O
    Auris Nasus Larynx; 2016 Dec; 43(6):637-40. PubMed ID: 27036360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mometasone furoate nasal spray in the treatment of adenoidal hypertrophy in the adolescents: a prospective, randomized, cross-over study.
    Yilmaz HB; Celebi S; Sahin-Yilmaz A; Oysu C
    Eur Arch Otorhinolaryngol; 2013 Sep; 270(10):2657-61. PubMed ID: 23381494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mometasone furoate intranasal spray is effective in reducing symptoms and adenoid size in children and adolescents with adenoid hypertrophy.
    Ghafar MHA; Mohamed H; Mohammad NMY; Mohammad ZW; Madiadipoera T; Wang Y; Abdullah B
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(3):147-153. PubMed ID: 31400807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study.
    Berlucchi M; Salsi D; Valetti L; Parrinello G; Nicolai P
    Pediatrics; 2007 Jun; 119(6):e1392-7. PubMed ID: 17533178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps.
    Vuralkan E; Saka C; Akin I; Hucumenoglu S; Unal BU; Kuran G; Ocal B
    Ther Adv Respir Dis; 2012 Feb; 6(1):5-10. PubMed ID: 22042749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of topical mometasone furoate on adenoidal lymphoid tissue: a light microscopic study.
    Ahmed MR; Abou-Halawa AS; Ibrahim IH; Zittoon RF; Makary EFY
    J Laryngol Otol; 2019 Feb; 133(2):106-109. PubMed ID: 30616699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion.
    Bhargava R; Chakravarti A
    Am J Otolaryngol; 2014; 35(6):766-70. PubMed ID: 25151658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does atopy influence the effectiveness of treatment of adenoid hypertrophy with mometasone furoate?
    Rezende RM; Amato FS; Barbosa AP; Menezes UP; Rezende P; Ferriani VP; Anselmo-Lima WT; Valera FC
    Am J Rhinol Allergy; 2015; 29(1):54-6. PubMed ID: 25590321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effect of montelukast sodium combined with inhaled corticosteroids in the treatment of OSAS children.
    Yang DZ; Liang J; Zhang F; Yao HB; Shu Y
    Medicine (Baltimore); 2017 May; 96(19):e6628. PubMed ID: 28489737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Outcomes Between Mometasone Furoate Intranasal Spray and Oral Montelukast in Patients with Allergic Rhinitis.
    Bhattachan S; Neupane Y; Pradhan B; Thapa N
    J Nepal Health Res Counc; 2020 Sep; 18(2):268-270. PubMed ID: 32969391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray.
    Meltzer EO; Jalowayski AA; Orgel HA; Harris AG
    J Allergy Clin Immunol; 1998 Jul; 102(1):39-49. PubMed ID: 9679846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of children undergoing topical intranasal steroid therapy for adenoidal hypertrophy.
    Berlucchi M; Valetti L; Parrinello G; Nicolai P
    Int J Pediatr Otorhinolaryngol; 2008 Aug; 72(8):1171-5. PubMed ID: 18499270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.